Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00058
|
|||||
| Drug Name |
Perindopril
|
|||||
| Synonyms |
(2S)-2-[(1S)-1-Carbethoxybutylamino]-1-oxopropyl-(2S,3aS,7aS)-perhydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid; ACEON; Aceon (TN); Acertil (TN); Armix (TN); Coverene (TN); Coverene Cor; Coverex; Coverex (TN); Coversum; Coversum (TN); Coversyl; Cpd with unspecified MF; DW-7950; Ethyl N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvalinate; McN-A-2833; Perindopril (USAN/INN); Prestarium; Prestarium (TN); Prexanil (TN); Prexum (TN); Procaptan (TN); S-9490; SED-9490
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | High blood pressure [ICD11: BA00] | Approved | [1] | |||
| Therapeutic Class |
Antihypertensive Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H32N2O5
|
|||||
| Canonical SMILES |
CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O
|
|||||
| InChI |
InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14-,15-,16-/m0/s1
|
|||||
| InChIKey |
IPVQLZZIHOAWMC-QXKUPLGCSA-N
|
|||||
| CAS Number |
CAS 107133-36-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 368.5 | Topological Polar Surface Area | 95.9 | ||
| Heavy Atom Count | 26 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
0.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10234445
, 103589744
, 104379782
, 11364904
, 11367466
, 11370028
, 11372525
, 11374329
, 11378198
, 11484952
, 11488924
, 11491498
, 11492590
, 11495762
, 12013509
, 121363719
, 124800274
, 126655685
, 128203001
, 134338091
, 134358176
, 135047729
, 137002499
, 143493278
, 144206638
, 14755214
, 14803882
, 152235952
, 152344316
, 160964132
, 162178238
, 163137224
, 170464836
, 17397842
, 175265414
, 44436758
, 46508767
, 48035415
, 48259509
, 48416399
, 50065440
, 53787258
, 53801152
, 56463760
, 57338263
, 78106573
, 7980282
, 85788931
, 93166944
, 9908
|
|||||
| ChEBI ID |
ChEBI:8025
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [2] | |
| PEPT2 | Transporter Info | Peptide transporter 2 | Substrate | [2] | ||
| References | ||||||
| 1 | Perindopril was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited. J Pharmacol Exp Ther. 2008 Nov;327(2):432-41. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.